Relay Therapeutics, Inc.

RLAY·NasdaqGM·Healthcare
Compare
18.03+0.59 (+3.38%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market18.20+0.17 (+0.94%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close17.44
Open17.57
Day range17.0818.27
52-week range5.9521.27
Off day high−1.31%
Off 52-week high−15.23%
Volume3.73M
Avg. volume (3M)2.79M
Market cap3.95B
EPS (TTM)-1.56
Forward P/E-11.05
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.74
Shares outstanding219.14M
Short interest23.39% of float
Earnings dateNov 4, 2026
Analyst target27.58
Profit margin0.00%

Against its peers

Compare in full ›
RLAY ERAS 2256.HK IDYA SNDX TNGX
Market cap 3.95B 5.21B 5.03B 3.12B 940.80M 3.91B
P/E (TTM) — — — — — —
Forward P/E -11.0 -23.9 -24.1 -7.9 -14.4 -13.8
Price/book 5.5 12.9 2.0 2.9 -54.7 3.8
Dividend yield — — — — — —
1-year change +166.26% +565.45% −54.94% +5.63% −5.36% +208.52%
Today +3.38% +1.84% +6.85% +3.29% −26.87% +0.04%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All RLAY news ›
Defense World··2 outletsPositive

Praxis Precision Medicines (NASDAQ:PRAX) and Relay Therapeutics (NASDAQ:RLAY) Financial Review

Posted by Defense World Staff on Oct 27th, 2026 Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will…

More from 1 other outlet
Stock Titan·

Relay Therapeutics CEO sells 48,199 shares

CEO sells 48,199 shares under a trading plan at Relay Therapeutics (RLAY). Stock Titan - [Form 4] Relay Therapeutics, Inc. Insider Trading Activity Relay Therapeutics CEO sells 48,199 shares The sale was made under a Rule 10b5-1 plan…

Stock Titan·

Relay Therapeutics CFO sells 17,511 shares

Relay Therapeutics (RLAY) is a Nasdaq-listed clinical-stage precision medicine company using its Dynamo platform to develop small molecule therapies for cancer and genetic disease. - [Form 4] Relay Therapeutics, Inc. Insider Trading…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance